Metabolic-Fit / 100
Sumbare Wellness review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
Sumbare's pitch is warmth — "a team that celebrates every body" — and one price, "Plans from $120/mo · confirmed after provider review", with nothing broken out by drug or dose. The claim that needs checking is the one under its progress chart: "~15–20% avg. body-weight change", sourced to "multi-center, placebo-controlled national clinical trials of Compounded Semaglutide and Tirzepatide formulations". Those trials do not exist. Compounded medicines are not FDA-approved and are not put through registrational trials; those figures come from studies of the branded drugs.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
Sumbare Wellness at a glance
- Semaglutide
- From $120/mo, not confirmed until after provider review
- Tirzepatide
- Not priced separately on the site
- Coverage
- Not published — its own counter reads "0 states"
- Brand-name
- Compounded only
How we scored Sumbare Wellness
Every factor comes from Sumbare Wellness's own published pricing, disclosures and oversight, and the six combine into the 23/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
It publishes a single price — "Plans from $120/mo · confirmed after provider review" — with no breakdown by drug or dose, and no separate price for tirzepatide. Its headline "~15-20% avg. body-weight change" is attributed to clinical trials of compounded semaglutide and tirzepatide formulations; no such trials exist, and those figures come from studies of the branded drugs. Four separate stat counters render as zeros, including "0 states telehealth access" and "0.0 /5 Average care rating", and no refund or cancellation policy appears anywhere.
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $120 | Starting price, not confirmed until after review"Plans from $120 /mo · confirmed after provider review", described by the site as an "educational estimate only". |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what Sumbare Wellness's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- Names its operating entity and a mailing address
- "$0 if you're not approved" is stated plainly
- The inclusive framing is more than decoration — it addresses readers who have been dismissed by clinicians before
- Carries the disclosure that compounded medications are not FDA-approved
The caveats
- The "~15–20% avg. body-weight change" figure is attributed to clinical trials of compounded semaglutide and tirzepatide — no such trials exist; those results belong to studies of the branded drugs
- Only one price is published, "from $120/mo", and it is "confirmed after provider review"
- Tirzepatide is named in the sourcing footnote but has no price of its own
- The homepage stat block reads "0 states telehealth access", alongside "0 + People we've supported" and "0.0 /5 Average care rating" — unfilled counters, live
- An interactive chart presents "Week 12 Clinical Milestone -9.8%, Average reduction: -14.1 lbs" as though it described this program's patients
- No refund or cancellation policy appears anywhere on the site
A welcoming presentation still needs a complete quote
Sumbare Wellness presents itself as an inclusive service for people who may have felt dismissed in earlier healthcare encounters. That tone can make it easier to begin a conversation about weight, but should be distinguished from the actual clinical and financial agreement. The public starting figure is from $120 monthly, confirmed after provider review and described as an educational estimate. It is not a verified stand-alone monthly price for every person who applies.
The public treatment information does not break that estimate down by molecule, dose or supply. Tirzepatide is named without its own price. Ask which medication and formulation the clinician recommends, how much is dispensed and what the complete first and subsequent payments will be. A generic GLP-1 floor should not be treated as a specific semaglutide or tirzepatide quote, and a sympathetic message should not make a buyer feel obliged to accept an unclear recurring charge.
The progress graphic is not a personal forecast
Sumbare's interactive chart presents numerical weight-loss milestones and an average reduction. Its surrounding language attributes a broader percentage change to trials described as involving compounded semaglutide and tirzepatide formulations. The public information does not establish the study details needed to treat those figures as measured results of Sumbare's own patients or its offered preparations. A trial result for a branded medicine cannot automatically be relabeled as the outcome of a compounded telehealth program.
The company also discloses that compounded medicines are not FDA-approved. Read that statement alongside the outcome presentation rather than allowing either to obscure the other. Ask the prescriber to identify the preparation and clinical rationale. A graphic showing progress over time does not tell an individual patient how she will respond, establish an appropriate dose or show that a larger financial commitment improves the result. The actual treatment plan needs its own explanation.
Empty counters do not answer the availability question
The homepage statistics display zero for state access, people supported and a care rating. Those counters should not be read as proof that the company cannot treat anyone, but they also cannot substantiate a patient count, rating or service footprint. Ask directly whether the prescribing practice and dispensing arrangement can serve the intended address. An online appearance and an inclusive message do not replace geographic eligibility for a particular medicine.
Sumbare identifies an operating entity and mailing address, which supplies basic business accountability without identifying every clinical professional involved. Request the treating practice, dispensing pharmacy and contact method for questions between supplies. If the platform and independent clinicians have different responsibilities, understand which organization handles clinical changes and which handles payment. That distinction can make a later concern easier to resolve than relying on one general help message for every part of care.
Approval and cancellation are separate conditions
The site says there is no charge if a patient is not approved. That is useful information about the initial prescribing decision, but does not establish the refund rules after approval. A cancellation or refund policy is not supplied in its public information. Ask when a prescription order becomes final, which charges can recur and how to pause or stop them before authorizing payment, particularly if the proposed quote covers more than one supply.
Sumbare may be relevant to someone who values its welcoming approach and receives a clear, affordable prescription offer. The next step is to establish the medicine, complete bill, local access and exit terms together. Its public presentation does not establish a dedicated postpartum or hormonal specialty, so ask about those needs rather than inferring them from general inclusivity. A good decision should preserve the sense of being heard while still requiring a concrete clinical relationship and understandable financial commitments.
The bottom line for mothers
Best for: Difficult to answer, because the site fixes almost nothing before you hand over a medical history.
Alternatives to Sumbare Wellness
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit SnagRx56
Metabolic-Fit / 100
Compounded semaglutide at $99 a month and tirzepatide at $149, month to month, one price at every dose that SnagRx says covers the medication, the supplies, the doctor review and shipping, with no membership fee and cancellation by email or phone. The $69 and $119 on its homepage are the 12-month prepay rates, billed once up front with no refund for unused months, and they sit under a live countdown clock with a lock-for-life promise that is marketing rather than a published term. It ships from licensed US pharmacies it never names, and publishes no list of the states it serves.
- Visit Peter MD36
Metabolic-Fit / 100
Real pre-intake pricing on its GLP-1 pages ($149/mo semaglutide-class B12 combo, $249/mo tirzepatide billed quarterly) inside a much broader TRT-and-men's-health platform — with a strict cancellation policy that refuses cancellations inside 48 hours of a renewal.
Providers like Sumbare Wellness
Keep comparing Sumbare Wellness
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
Sumbare Wellness, answered
- How much does Sumbare Wellness cost?
- At last review, Sumbare Wellness's lowest ongoing compounded rate was about $120/mo — From $120/mo, not confirmed until after provider review for semaglutide, Not priced separately on the site for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
- Is Sumbare Wellness safe to use while breastfeeding?
- No GLP-1 is established as safe in pregnancy. Nursing is less clear-cut. The Wegovy injection and Ozempic labels have little or no breast-milk data and ask you and your clinician to weigh the benefits of breastfeeding against how much you need the drug. Compounded versions carry no label of their own, which puts more of that judgment on your prescriber. Sumbare Wellness is not an exception to any of that — settle the timing with your own clinician.
- Does Sumbare Wellness offer both semaglutide and tirzepatide?
- Sumbare Wellness's tirzepatide access isn't consistently disclosed; it's primarily a semaglutide program as last verified. If you specifically want tirzepatide, confirm availability first.
- How does Sumbare Wellness score for mothers?
- Sumbare Wellness scores 23/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect Sumbare Wellness's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.